Q1 2024 Chemours Co Earnings Call Transcript
Key Points
- The Chemours Co (CC) reported that their TT segment met top line expectations for the quarter, with adjusted EBITDA performing better than anticipated.
- The company successfully allocated TiO2 volumes to higher-yield regions, which contributed positively to their profitability.
- The transformation plan of The Chemours Co (CC) is showing strong results, leading to significant cost savings and securing a long-term leadership position by aiming to become one of the lowest-cost TiO2 producers globally.
- The TSS segment of The Chemours Co (CC) leveraged its advantage in Opteon stationary blends to support the transition to low GWP solutions, benefiting from regulatory step downs in the U.S. and Europe.
- The company maintained a strong liquidity position with $1.6 billion, including $746 million in unrestricted cash and cash equivalents and $853 million in revolver capacity.
- Consolidated net sales for the first quarter decreased to $1.4 billion from $1.5 billion in the same period of 2023, reflecting a decline in volumes and price across all three business segments.
- Consolidated adjusted EBITDA decreased by 37% year-over-year from $304 million to $193 million, primarily due to demand weakness and lower cost absorption.
- The APM segment experienced a significant decline in net sales and adjusted EBITDA, driven by weaker demand in economically sensitive and nonstrategic end markets.
- The TSS segment saw a decrease in net sales and adjusted EBITDA, influenced by weaker legacy refrigerant pricing and higher market inventory levels.
- The company anticipates expenses related to the remediation of material weaknesses to continue, potentially impacting financial performance.
Good morning. My name is Lovely, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company First Quarter 2024 Results Conference Call.
(Operator Instructions) I would like to remind everyone that this call -- conference call is being recorded. I would now like to hand the conference call over to Brandon Ontjes, Vice President of Investor Relations for Chemours. You may now begin your conference.
Good morning, everybody. Welcome to The Chemours Company's First Quarter 2024 Earnings Conference Call. I'm joined today by Denise Dignam, Chemour's President and Chief Executive Officer; and our Interim Chief Financial Officer, Matt Abbott.
Before we start, I would like to remind you that comments made on this call as well as in the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties as described in Chemours' SEC filings. These forward-looking statements are not
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
